Digital Person (920670) Plans to Use No More Than 120 Million Yuan of Its Own Funds to Purchase Financial Products to Improve Efficiency of Its Own Fund Utilization

On March 13, Shandong Digital Human Technology Co., Ltd. announced that in order to improve the efficiency and returns of the company’s short-term idle funds and maximize shareholder interests, while ensuring that funds needed for daily operations and liquidity and safety are not affected, the company plans to use no more than RMB 120 million of its idle funds by 2026 to purchase high-security, highly liquid, low-risk financial products with a risk level not exceeding R3 to generate additional income.

According to industry sources, the company is a national high-tech enterprise and a specialized, innovative “Little Giant” enterprise. It focuses on software development in the digital medical field, with years of experience in this area. Its core technologies include digital human visualization, multi-modal data fusion analysis, and innovations in layered image segmentation, 3D reconstruction, and visualization. The company engages in the research and development and application promotion of “digital human technology,” providing medical education informatization products and comprehensive solutions.

Centered on technological innovation, the company focuses on digital anatomy technology and smart education, with many years of experience in the digital medical industry. It is committed to promoting high-quality, standardized industry development. The core R&D team consists of over 120 interdisciplinary professionals in fields such as computer technology, clinical medicine, and anatomy. All key technical personnel have more than 10 years of industry experience. The team combines strong technical expertise, practical experience, and outstanding independent innovation capabilities. This foundation supports breakthroughs in digital anatomy technology, product iteration and upgrades, and large-scale application deployment, creating high industry barriers and maintaining the company’s leading position in core technology.

The company has also built a leading domestic full-chain platform for digital anatomy technology R&D and application, covering high-precision digital anatomy data collection, specialized processing, detailed 3D modeling, immersive visualization, and integration of virtual reality (VR), augmented reality (AR), and extended reality (XR) applications. This platform enables full control from technology development to product implementation, meeting diverse digital anatomy needs in medical education, clinical training, and public health displays. It can quickly respond to market changes and customer needs, providing comprehensive technical support for technology deployment, product promotion, and industry deepening, effectively solving industry pain points and forming a cycle of “R&D - platform - application.”

Relying on these core advantages, the company adheres to an innovation-driven, technology-enabled development path, continuously deepening core technology R&D, and steadily expanding globally. It aims to optimize educational resource allocation and promote fair sharing, driving the transformation of the education industry toward intelligence, personalization, and diversification, supporting the realization of modernization and high-quality development goals in education.

By the end of 2025, the company holds 19 invention patents and 79 copyrights, providing strong technical reserves and support for new product development. It received the third prize of Shandong Provincial Science and Technology Progress Award in 2014 and the second prize of National Teaching Achievement in 2018. After years of experience and technological accumulation, the company has developed integrated product designs, comprehensive solutions, and rich experience in product application, gradually establishing a unique competitive advantage. In high-definition digital human development, it uses high-precision human data as the core technology base, conducting research on neurosurgical approach simulation and digital human deformation, building highly realistic surgical training systems, and transforming neurosurgical training from experience-driven to data-driven and precision-driven, shortening learning curves and reducing early clinical operation risks, providing technical support for neurosurgical research. In digital human deformation, leveraging digital human model data and deformable digital Chinese human technology, combined with multi-modal information data to drive parameterized deformation, the company can generate digital human maps with different postures and internal structures under various weights, creating personalized, high-precision, dynamically adaptable digital twin images for anatomical display and functional analysis. Based on user historical data, it can also provide health assessments, disease risk predictions, and health recommendations.

These research efforts will effectively break through the technical limitations of traditional medical research, promote the deep transformation and large-scale application of high-definition digital human data in medicine, and support the achievement of precise diagnosis and treatment, intelligent surgical training, and personalized health management goals. The company’s future expansion into multiple industries and products is built on a solid foundation. It plans to gradually extend its business from medical education to clinical medical simulation and public health fields.

After years of operation, the company has established a good reputation in the industry through comprehensive solutions and excellent customer service. Its products cover over 60% of the market, with stable customer resources, high market share, and a strong brand image, providing a solid foundation for sustained high-quality development.

In terms of performance, in 2025, the company achieved operating revenue of RMB 99.65 million, a year-on-year increase of 50.22%; net profit attributable to shareholders of the listed company was RMB 8.18 million, a year-on-year increase of 296.77%.